Diagnostic performance of 18F-fluorodeoxyglucose PET/computed tomography in primary tumor localization and its impact on management in patients with metastases of unknown origin: a cross-sectional study.

Mahmoud HA, Ibrahim EMA, Mekkawy MA, Mahmoud NM

Open source

DOI
10.1097/mnm.0000000000002267
Published
2026 Nov 10
Container
Nuclear medicine communications
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/mnm.0000000000002267,
  title = {Diagnostic performance of 18F-fluorodeoxyglucose PET/computed tomography in primary tumor localization and its impact on management in patients with metastases of unknown origin: a cross-sectional study.},
  author = {Mahmoud HA and Ibrahim EMA and Mekkawy MA and Mahmoud NM},
  year = {2026},
  journal = {Nuclear medicine communications},
  doi = {10.1097/mnm.0000000000002267},
  url = {https://doi.org/10.1097/mnm.0000000000002267}
}

RIS

TY  - JOUR
TI  - Diagnostic performance of 18F-fluorodeoxyglucose PET/computed tomography in primary tumor localization and its impact on management in patients with metastases of unknown origin: a cross-sectional study.
AU  - Mahmoud HA
AU  - Ibrahim EMA
AU  - Mekkawy MA
AU  - Mahmoud NM
PY  - 2026
JO  - Nuclear medicine communications
DO  - 10.1097/mnm.0000000000002267
UR  - https://doi.org/10.1097/mnm.0000000000002267
ER  - 

APA

HA, M., EMA, I., MA, M., & NM, M. (2026). Diagnostic performance of 18F-fluorodeoxyglucose PET/computed tomography in primary tumor localization and its impact on management in patients with metastases of unknown origin: a cross-sectional study.. Nuclear medicine communications. https://doi.org/10.1097/mnm.0000000000002267

Source records